These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22941207)

  • 41. Practical use of airway pressure release ventilation for severe ARDS--a preliminary report in comparison with a conventional ventilatory support.
    Liu L; Tanigawa K; Ota K; Tamura T; Yamaga S; Kida Y; Kondo T; Ishida M; Otani T; Sadamori T; Tsumura R; Takeda T; Iwasaki Y; Hirohashi N
    Hiroshima J Med Sci; 2009 Dec; 58(4):83-8. PubMed ID: 20349751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterotopic ossification due to neuromuscular blocking agent in adult respiratory distress syndrome. A case report.
    Zynnurodlu M; Kaymak Karatap G; Sepycy V
    Eur J Phys Rehabil Med; 2008 Mar; 44(1):81-5. PubMed ID: 18385631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sedation an acute respiratory distress syndrome].
    Boyadjiev I; Albanèse J
    Ann Fr Anesth Reanim; 2008; 27(7-8):604-10. PubMed ID: 18585000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are corticosteroids useful in late-stage acute respiratory distress syndrome?
    Sessler CN; Gay PC
    Respir Care; 2010 Jan; 55(1):43-55. PubMed ID: 20040123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors of mortality in road traffic injury patients with acute respiratory distress syndrome.
    Zhao XG; Wu JS; He XD; Ma YF; Zhang M; Gan JX; Xu SW; Jiang GY
    Chin Med J (Engl); 2008 Jun; 121(11):968-72. PubMed ID: 18706242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How relaxed should we be with acute respiratory distress syndrome?
    Freebairn R
    Crit Care Med; 2004 Jan; 32(1):296-8. PubMed ID: 14707600
    [No Abstract]   [Full Text] [Related]  

  • 49. One-year experience with an acute respiratory distress syndrome standard operating procedure on intensive care unit.
    Luedike P; Totzeck M; Rammos C; Kindgen-Milles D; Kelm M; Rassaf T
    J Crit Care; 2015 Oct; 30(5):1114-8. PubMed ID: 26216357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute lung injury and acute respiratory distress syndrome at the intensive care unit of a general university hospital in Brazil. An epidemiological study using the American-European Consensus Criteria.
    Fialkow L; Vieira SR; Fernandes AK; Silva DR; Bozzetti MC;
    Intensive Care Med; 2002 Nov; 28(11):1644-8. PubMed ID: 12415455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological therapies for acute respiratory distress syndrome.
    Spieth PM; Zhang H
    Curr Opin Crit Care; 2014 Feb; 20(1):113-21. PubMed ID: 24335654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review.
    Paramore S
    J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular blocking agents in ARDS.
    Slutsky AS
    N Engl J Med; 2010 Sep; 363(12):1176-80. PubMed ID: 20843254
    [No Abstract]   [Full Text] [Related]  

  • 55. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome.
    Bajwa EK; Yu CL; Gong MN; Thompson BT; Christiani DC
    Crit Care Med; 2007 May; 35(5):1290-5. PubMed ID: 17414088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous breathing activity in acute lung injury and acute respiratory distress syndrome.
    Gama de Abreu M; Güldner A; Pelosi P
    Curr Opin Anaesthesiol; 2012 Apr; 25(2):148-55. PubMed ID: 22227446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A risk tertiles model for predicting mortality in patients with acute respiratory distress syndrome: age, plateau pressure, and P(aO(2))/F(IO(2)) at ARDS onset can predict mortality.
    Villar J; Pérez-Méndez L; Basaldúa S; Blanco J; Aguilar G; Toral D; Zavala E; Romera MA; González-Díaz G; Nogal FD; Santos-Bouza A; Ramos L; Macías S; Kacmarek RM;
    Respir Care; 2011 Apr; 56(4):420-8. PubMed ID: 21255500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraoperative risk factors for acute respiratory distress syndrome in critically ill patients.
    Hughes CG; Weavind L; Banerjee A; Mercaldo ND; Schildcrout JS; Pandharipande PP
    Anesth Analg; 2010 Aug; 111(2):464-7. PubMed ID: 20418537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuromuscular blockers and ARDS.
    Puthucheary Z; Hart N; Montgomery H
    N Engl J Med; 2010 Dec; 363(26):2563. PubMed ID: 21175320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.